Opioid Treatment Program (OTP) Development

Opioid Treatment Program (OTP) Development Consulting

Opioid Treatment Programs that dispense methadone for the treatment of opioid use disorder are subject to a unique set of federal requirements administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Administration (DEA). These regulations govern everything from the physical dispensing facility to staffing ratios, take-home medication schedules, counseling requirements, and medical director qualifications.

Despite this complexity, OTPs remain among the most effective evidence-based treatments available for opioid use disorder. Well-run programs significantly reduce overdose mortality, criminal justice involvement, and comorbid health conditions among the populations they serve. Our OTP consultants have helped organizations launch new programs and strengthen existing ones — navigating federal requirements without losing sight of the clinical mission.

Regulatory Framework We Navigate

• 42 CFR Part 8 — Federal methadone regulations governing OTP certification, staffing, dosing, take-home privileges, and recordkeeping

• SAMHSA OTP Certification — Federal certification application and ongoing compliance with SAMHSA's Division of Pharmacologic Therapies (DPT)

• DEA Schedule II Registration — Federal DEA registration for methadone dispensing, including security requirements, inventory controls, and diversion prevention

• State OTP Licensure — Many states impose additional requirements beyond federal regulations, including state-specific staffing ratios, facility standards, and reporting obligations

• Accreditation Requirements — Most OTPs are required to be accredited by a SAMHSA-approved accrediting body (CARF, The Joint Commission, or ACHC)

Service Areas

• OTP Feasibility & Market Assessment — Community need analysis, competitive landscape review, and financial viability modeling for a proposed OTP

• SAMHSA Certification Application — Full application preparation and submission support for new OTP federal certification

• DEA Registration Guidance — Documentation and process support for Schedule II DEA registration and security compliance

• State Licensure Applications — State-specific OTP licensure application preparation in all applicable states

• Facility Design Guidance — Consultation on dispensing window design, medication storage, waiting area layout, and physical security requirements

• Clinical Program Design — Evidence-based counseling protocols, dosing algorithms, take-home criteria, and co-occurring disorder treatment integration

• Policies & Procedures Manual — A complete OTP policy manual covering all federal, state, and accreditation requirements

• Staff Training — Medical director, nursing, counseling, and administrative staff training on OTP regulations and clinical best practices

Ready to Build or Strengthen Your SUD Program?

Buprenorphine-based office-based opioid treatment (OBOT) programs operate under a different regulatory framework than methadone OTPs. We support both models, as well as hybrid programs offering both medications based on patient clinical need.